Left main and bifurcation stenting

Area of Science:

• Cardiology
• Interventional Cardiology
• Vascular Surgery

Background:

• Unprotected left main coronary artery disease (ULMD) traditionally treated with CABG.
• Advancements in stent technology and operator experience have increased PCI use for LM lesions.
• Optimal patient selection is crucial for successful bifurcation stenting in LM disease.

Purpose of the Study:

• To review the current landscape of revascularization for unprotected left main coronary artery disease.
• To compare the outcomes of CABG and PCI for LM disease.
• To identify areas for future research in LM disease treatment.

Main Methods:

• Review of existing literature and clinical trials comparing CABG and PCI for LM disease.
• Analysis of patient selection criteria for PCI in LM disease.
• Discussion of bifurcation stenting techniques and outcomes.

Main Results:

• CABG is the established gold standard for ULMD.
• PCI has emerged as a viable alternative, particularly for distal LM lesions, due to technological improvements.
• Patient selection and operator experience significantly influence PCI outcomes.

Conclusions:

• Both CABG and PCI are effective revascularization strategies for LM disease.
• Further randomized trials are essential to precisely define indications for CABG versus PCI.
• Optimizing patient selection and technique is key for successful LM interventions.